Where the Sun shines: Industry's payments to transplant surgeons

R. Ahmed, E. K. Chow, Allan B Massie, S. Anjum, Elizabeth King, B. J. Orandi, S. Bae, Lauren Nicholas, B. E. Lonze, Dorry Segev

Research output: Contribution to journalArticle

Abstract

The Open Payments Program (OPP) was recently implemented to publicly disclose industry payments to physicians, with the goal of enabling patient awareness of potential conflicts of interests. Awareness of OPP, its data, and its implications for transplantation are critical. We used the first wave of OPP data to describe industry payments made to transplant surgeons. Transplant surgeons (N = 297) received a total of $759 654. The median (interquartile range [IQR]) payment to a transplant surgeon was $125 ($39-1018), and the highest payment to an individual surgeon was $83 520; 122 surgeons received $10 000. A higher h-index was associated with 30% higher chance of receiving >$1000 (relative risk/10 unit h-index increase = 1.181.301.44, p <0.001). The highest payment category was consulting fees, with a total of $314 448 paid in this reported category. Recipients of consulting fees had higher h-indices, median (IQR) of 20 (10-35) versus nine (3-17) (p <0.001). Ten of 122 companies accounted for 62% of all payments. Kidney transplant and liver transplant (LT) centers that received >$1000 had higher center volumes (p <0.001). LT centers that received payments of >$1000 had a higher percentage of private-insurance/self-pay patients (p <0.01). Continued surveillance of industry payments may further elucidate the relationship between industry payments and physician practices. In this study, the authors quantify and characterize all industry payments made to transplant surgeons, now publicly available under the Physician Payment Sunshine Act.

Original languageEnglish (US)
Pages (from-to)292-300
Number of pages9
JournalAmerican Journal of Transplantation
Volume16
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Solar System
Industry
Transplants
Physicians
Conflict of Interest
Sunlight
Insurance
Surgeons
Transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Where the Sun shines : Industry's payments to transplant surgeons. / Ahmed, R.; Chow, E. K.; Massie, Allan B; Anjum, S.; King, Elizabeth; Orandi, B. J.; Bae, S.; Nicholas, Lauren; Lonze, B. E.; Segev, Dorry.

In: American Journal of Transplantation, Vol. 16, No. 1, 01.01.2016, p. 292-300.

Research output: Contribution to journalArticle

Ahmed, R. ; Chow, E. K. ; Massie, Allan B ; Anjum, S. ; King, Elizabeth ; Orandi, B. J. ; Bae, S. ; Nicholas, Lauren ; Lonze, B. E. ; Segev, Dorry. / Where the Sun shines : Industry's payments to transplant surgeons. In: American Journal of Transplantation. 2016 ; Vol. 16, No. 1. pp. 292-300.
@article{6f3d2088541d41ed9641a5309b0346ce,
title = "Where the Sun shines: Industry's payments to transplant surgeons",
abstract = "The Open Payments Program (OPP) was recently implemented to publicly disclose industry payments to physicians, with the goal of enabling patient awareness of potential conflicts of interests. Awareness of OPP, its data, and its implications for transplantation are critical. We used the first wave of OPP data to describe industry payments made to transplant surgeons. Transplant surgeons (N = 297) received a total of $759 654. The median (interquartile range [IQR]) payment to a transplant surgeon was $125 ($39-1018), and the highest payment to an individual surgeon was $83 520; 122 surgeons received $10 000. A higher h-index was associated with 30{\%} higher chance of receiving >$1000 (relative risk/10 unit h-index increase = 1.181.301.44, p <0.001). The highest payment category was consulting fees, with a total of $314 448 paid in this reported category. Recipients of consulting fees had higher h-indices, median (IQR) of 20 (10-35) versus nine (3-17) (p <0.001). Ten of 122 companies accounted for 62{\%} of all payments. Kidney transplant and liver transplant (LT) centers that received >$1000 had higher center volumes (p <0.001). LT centers that received payments of >$1000 had a higher percentage of private-insurance/self-pay patients (p <0.01). Continued surveillance of industry payments may further elucidate the relationship between industry payments and physician practices. In this study, the authors quantify and characterize all industry payments made to transplant surgeons, now publicly available under the Physician Payment Sunshine Act.",
author = "R. Ahmed and Chow, {E. K.} and Massie, {Allan B} and S. Anjum and Elizabeth King and Orandi, {B. J.} and S. Bae and Lauren Nicholas and Lonze, {B. E.} and Dorry Segev",
year = "2016",
month = "1",
day = "1",
doi = "10.1111/ajt.13427",
language = "English (US)",
volume = "16",
pages = "292--300",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Where the Sun shines

T2 - Industry's payments to transplant surgeons

AU - Ahmed, R.

AU - Chow, E. K.

AU - Massie, Allan B

AU - Anjum, S.

AU - King, Elizabeth

AU - Orandi, B. J.

AU - Bae, S.

AU - Nicholas, Lauren

AU - Lonze, B. E.

AU - Segev, Dorry

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The Open Payments Program (OPP) was recently implemented to publicly disclose industry payments to physicians, with the goal of enabling patient awareness of potential conflicts of interests. Awareness of OPP, its data, and its implications for transplantation are critical. We used the first wave of OPP data to describe industry payments made to transplant surgeons. Transplant surgeons (N = 297) received a total of $759 654. The median (interquartile range [IQR]) payment to a transplant surgeon was $125 ($39-1018), and the highest payment to an individual surgeon was $83 520; 122 surgeons received $10 000. A higher h-index was associated with 30% higher chance of receiving >$1000 (relative risk/10 unit h-index increase = 1.181.301.44, p <0.001). The highest payment category was consulting fees, with a total of $314 448 paid in this reported category. Recipients of consulting fees had higher h-indices, median (IQR) of 20 (10-35) versus nine (3-17) (p <0.001). Ten of 122 companies accounted for 62% of all payments. Kidney transplant and liver transplant (LT) centers that received >$1000 had higher center volumes (p <0.001). LT centers that received payments of >$1000 had a higher percentage of private-insurance/self-pay patients (p <0.01). Continued surveillance of industry payments may further elucidate the relationship between industry payments and physician practices. In this study, the authors quantify and characterize all industry payments made to transplant surgeons, now publicly available under the Physician Payment Sunshine Act.

AB - The Open Payments Program (OPP) was recently implemented to publicly disclose industry payments to physicians, with the goal of enabling patient awareness of potential conflicts of interests. Awareness of OPP, its data, and its implications for transplantation are critical. We used the first wave of OPP data to describe industry payments made to transplant surgeons. Transplant surgeons (N = 297) received a total of $759 654. The median (interquartile range [IQR]) payment to a transplant surgeon was $125 ($39-1018), and the highest payment to an individual surgeon was $83 520; 122 surgeons received $10 000. A higher h-index was associated with 30% higher chance of receiving >$1000 (relative risk/10 unit h-index increase = 1.181.301.44, p <0.001). The highest payment category was consulting fees, with a total of $314 448 paid in this reported category. Recipients of consulting fees had higher h-indices, median (IQR) of 20 (10-35) versus nine (3-17) (p <0.001). Ten of 122 companies accounted for 62% of all payments. Kidney transplant and liver transplant (LT) centers that received >$1000 had higher center volumes (p <0.001). LT centers that received payments of >$1000 had a higher percentage of private-insurance/self-pay patients (p <0.01). Continued surveillance of industry payments may further elucidate the relationship between industry payments and physician practices. In this study, the authors quantify and characterize all industry payments made to transplant surgeons, now publicly available under the Physician Payment Sunshine Act.

UR - http://www.scopus.com/inward/record.url?scp=84956882239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956882239&partnerID=8YFLogxK

U2 - 10.1111/ajt.13427

DO - 10.1111/ajt.13427

M3 - Article

C2 - 26317315

AN - SCOPUS:84956882239

VL - 16

SP - 292

EP - 300

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 1

ER -